Published in Drug Week, October 31st, 2008
In the United States, PCI has become a common treatment strategy for patients with stable coronary artery disease (CAD), and its use has increased substantially over the past decade. "However, multiple studies have established that some important outcomes for patients with stable CAD (death and risk of future...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.